Wu YF, Li X, Ma J, Ma DY, Zeng XM, Yu QW, Chen WG. Primary prostate Burkitt's lymphoma resected with holmium laser enucleation of the prostate: A rare case report. World J Clin Cases 2023; 11(18): 4406-4411 [PMID: 37449230 DOI: 10.12998/wjcc.v11.i18.4406]
Corresponding Author of This Article
Yu-Fan Wu, MD, Doctor, Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, No. 388 Zuchongzhi Road, Kunshan 215300, Jiangsu Province, China. 20224132067@stu.suda.edu.cn
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Yu-Fan Wu, Jun Ma, Xue-Ming Zeng, Qi-Wei Yu, Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan 215300, Jiangsu Province, China
Yu-Fan Wu, Xiang Li, Wei-Guo Chen, Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu Province, China
Dan-Yu Ma, Department of Oncology, The Third Affiliated Hospital of Soochow University, Suzhou 215300, Jiangsu Province, China
Author contributions: Wu YF and Li X contributed to manuscript writing and editing, and data collection; Ma J, Ma DY, and Zeng XM contributed to data analysis; Yu QW and Chen WG contributed to conceptualization and supervision; all authors have read and approved the final manuscript.
Supported bythe Kunshan Research and Development Project, No. KSZ2203; the Kunshan Research and Development Project, No. KZYY2205.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yu-Fan Wu, MD, Doctor, Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, No. 388 Zuchongzhi Road, Kunshan 215300, Jiangsu Province, China. 20224132067@stu.suda.edu.cn
Received: March 27, 2023 Peer-review started: March 27, 2023 First decision: May 8, 2023 Revised: May 10, 2023 Accepted: May 24, 2023 Article in press: May 24, 2023 Published online: June 26, 2023 Processing time: 91 Days and 7.5 Hours
Abstract
BACKGROUND
Primary prostate Burkitt's lymphoma is a rare and aggressive condition with a poor prognosis. Its clinical presentation can be challenging to differentiate from benign prostatic hyperplasia. Given the rarity of primary prostate Burkitt's lymphoma, its diagnosis and treatment remain unclear.
CASE SUMMARY
This report presents a case of a 57-year-old male with primary prostate Burkitt's lymphoma, initially misdiagnosed as prostatic hyperplasia. This case's operative process, intraoperative findings and postoperative management are discussed in detail.
CONCLUSION
Primary prostate lymphoma is difficult to distinguish from other prostate diseases. Holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure, is crucial in diagnosing and treating this rare disease. Clinicians should remain vigilant and thoroughly combine physical examination, imaging and test results when encountering patients of younger age with small prostate size but a rapid progression of lower urinary tract symptoms. HoLEP is an essential diagnostic and therapeutic tool in managing primary prostate Burkitt's lymphoma.
Core Tip: Primary prostate Burkitt's lymphoma is a rare and aggressive condition with a poor prognosis. Combined with the analysis of the cases indexed in PubMed and RCA, Only three reports have previously documented Burkitt's lymphoma of the prostate. Holmium laser enucleation of the prostate (HoLEP) is an essential diagnostic and therapeutic tool in managing primary prostate Burkitt's lymphoma. Clinicians should remain vigilant and thoroughly combine physical examination, imaging and test results when encountering patients of younger age with small prostate size but a rapid progression of lower urinary tract symptoms.
